期刊文献+

中药治疗慢性疼痛的蛋白分子机制研究进展:文献综述 被引量:2

Research advances on molecular channel mechanism of traditional Chinese medicine in the treatment of chronic pain: a literature review
原文传递
导出
摘要 中药在治疗慢性疼痛方面有着巨大的潜在优势.中药治疗慢性疼痛的机制是同时通过多个分子通道协同作用,且涉及到炎症、免疫、血液循环、组织功能代谢等多方面的外周机制;同时也涉及N-甲基-D-天冬氨酸受体(NMDA)、P物质(SP)、单胺能等中枢神经递质受体机制和相关核基因转录机制等.中药具有止痛效果确切,对机体组织影响小,毒副作用少的特点,可长期应用,是疼痛治疗方法和止痛药物发掘的一个重要方向. Traditional Chinese medicine(TCM)has huge potential advantages in the treatment of chronic pain.The mechanism of TCM in treatment of chronic pain is a synergistic effects with multiple molecular pathways at the same time,and involves a variety of peripheral mechanisms such as inflammation,immunity,blood circulation,tissue function and metabolism as well as the receptor mechanism of N-methyl-D-aspartate receptor(NMDA),substance P(SP),monoaminergic and other central neurotransmitters and related nuclear gene transcription mechanisms.Treatment of chronic pain with TCM has a definite analgesic effect,little influence on the body tissue,long-term application,and low toxic and side effects.It is an important direction for the discovery of pain treatment method and analgesic drugs.
作者 陈少庚 党保安 Chen Shaogeng;Dang Baoan(Pain Treatment Center,Second Hospital of Tongchuan Mining Bureau,Tongchuan City,Shaanxi Province 727004,China)
出处 《实用疼痛学杂志》 2018年第5期383-388,共6页 Pain Clinic Journal
关键词 药理作用分子作用机制 慢性疼痛 中医药疗法 Molecular mechanisms of pharmacological action Chronic pain Therapy of traditional Chinese medicine
作者简介 通信作者:陈少庚,Email:534432138@qq.com
  • 相关文献

参考文献4

二级参考文献22

  • 1孙宏丽,王赫,孟然,周晋,焦军东,杨宝峰.三氧化二砷诱导QT间期延长及其离子靶点的实验研究[J].中国地方病学杂志,2005,24(5):488-490. 被引量:9
  • 2张莹,杜娟,张勇,孙宏丽,潘振伟,吕延杰,李宝馨,杨宝峰.苦参碱、氧化苦参碱和白藜芦醇对HERG钾通道表达的影响[J].药学学报,2007,42(2):139-144. 被引量:22
  • 3Emorine LJ, Marullo S, Briend-Sutren MM, et al. Molecular characterization of the human β3-adrenergic receptor. Science,1989,245 : 1118-1121.
  • 4Nantel F, Bonin H, Enorine LJ, et al. The human β3-adrenergic receptor is resistant to short term agonist-promoted desensitization. Mol Pharmacol, 1993,43 : 548 - 555.
  • 5Gauthier C, Langin D, Balligand JL.β3-adrenoceptors in the cardiovascular system. Tips, 2000,21 : 426 - 431.
  • 6Pelat M, Verwaerde P, Galitzky J, et al. High isoproterenol doses are required to activateβ3-adrenoceptor-mediated function in dogs. J Pharmacol Exp Ther,2003,30d. : 246 - 253.
  • 7Gauthier C, Tavernier G, Trochu J, et al. Interspecies differences in the cardiac negative inotropic effects of β3-adrenoceptor agonists. J Pharmacol Exp Ther, 1999,290 :687 - 693.
  • 8Gauthier C, Tavernier G, Charpentier F, et al. Functional β3-adrenoceptor in the human heart. J Clin Invest, 1996,98 : 556 - 562.
  • 9Gauthier C, Leblais V, Kobzik L, et al. The negative inotropic effect of β3-adrenoceptor stimulation is mediated by activation of a nitric oxide synthase pathway in human ventricle. J Clin Invest,1998,102 : 1377 - 1384.
  • 10Gauthier C, Leblais V, Moniotte S, et al. The negative inotropic action of catecholamines: role of β3-adrenoceptors.Can J Physiol Pharmacol,2000,78 : 681 - 690.

共引文献52

同被引文献32

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部